
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Healthy Children (American Academy of Pediatrics)
Pertussis (Whooping Cough) - What You Need to KnowCenters for Disease Control and Prevention






